Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Clinical trial NCT02116205 · COMPLETED
Trial details
- NCT number
- NCT02116205
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-07-09
- Primary completion
- 2016-12-07
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.